长春高新(000661.SZ)子公司三价流感病毒裂解疫苗(BK-01佐剂)临床试验申请获批准

智通财经10-13

智通财经APP讯，长春高新(000661.SZ)公告，公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》，同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2575408565?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-13 19:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575408565","market":"us","top_or_hot":-1,"title":"长春高新(000661.SZ)子公司三价流感病毒裂解疫苗(BK-01佐剂)临床试验申请获批准","media":"智通财经","content":"<div>\n<p>智通财经APP讯，长春高新(000661.SZ)公告，公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》，同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1354406.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>长春高新(000661.SZ)子公司三价流感病毒裂解疫苗(BK-01佐剂)临床试验申请获批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n长春高新(000661.SZ)子公司三价流感病毒裂解疫苗(BK-01佐剂)临床试验申请获批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-13 19:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1354406.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，长春高新(000661.SZ)公告，公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》，同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1354406.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861249.SGD","symbol_name":"Natixis Harris Associates US Equity PA SGD-H","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1354406.html","article_id":"2575408565","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575408565","pubTimestamp":1760353889,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，长春高新(000661.SZ)公告，公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》，同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"91272":"长春高新技术产业(集团)股份有限公司（临时代码）","159646":"疫苗","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","BK0075":"新三板","BK4585":"ETF&股票定投概念","BK":"纽约梅隆银行","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK0057":"长吉图板块","BK0239":"医药制造","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","BK0046":"生物疫苗","BK4559":"巴菲特持仓","BK4135":"资产管理与托管银行","BK0188":"融资融券","BK4588":"碎股","000661":"长春高新","LU1699723380.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"AP\" (USD) ACC","BK0028":"国家队"},"translate_title":"Changchun High-tech (000661. SZ) subsidiary trivalent influenza virus split vaccine (BK-01 adjuvant) clinical trial application approved","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91272":1.5,"159646":1.5,"000661":1.5,"BK":1.5},"content_text":"智通财经APP讯，长春高新(000661.SZ)公告，公司子公司百克生物收到国家药品监督管理局对其三价流感病毒裂解疫苗(BK-01佐剂)下发的《药物临床试验批准通知书》，同意开展预防疫苗相关型别流感病毒引起的流行性感冒的临床试验。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2575408565","isCrawlerRequest":true}